Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Disease Supported by Extracorporeal Membrane Oxygenation.

NCT05045885 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT05045885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Disease Supported by Extracorporeal Membrane Oxygenation.
Lead sponsor
Hamad Medical Corporation
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
December 1, 2020
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, extracorporeal membrane oxygenation complication, respiratory failure, tracheostomy complication